Characterization of protein components of human urinary crystal surface binding substance

[1]  K. Kohri,et al.  Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. , 1995, Urologia internationalis.

[2]  J. Dagorn,et al.  Analysis of the soluble organic matrix of five morphologically different kidney stones , 1995, Urological Research.

[3]  A. Okuyama,et al.  Heparan sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization , 1993, Urological Research.

[4]  K. Yoshida,et al.  Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. , 1992, Biochemical and biophysical research communications.

[5]  R. Ryall,et al.  Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. , 1991, Clinical chemistry.

[6]  E. Kaiser,et al.  Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. , 1983, The Journal of biological chemistry.

[7]  R. MacGillivray,et al.  Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. , 1983, Biochemistry.

[8]  W. N. Burnette,et al.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. , 1981, Analytical biochemistry.

[9]  M. Takaha,et al.  Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation. , 1981, Investigative urology.

[10]  W. Gill,et al.  Inhibitory effects of urinary macromolecules on the crystallization of calcium oxalate. , 1977, Investigative urology.

[11]  M. Peacock,et al.  Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[12]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[13]  H. Fleisch,et al.  Aggregation of calcium oxalate crystals: Effect of urine and various inhibitors , 2004, Urological Research.

[14]  M. Daudon,et al.  Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization , 2004, Urological Research.

[15]  S. Yamaguchi,et al.  Urinary crystal surface binding substances on calcium oxalate crystals , 2004, Urological Research.

[16]  F. Atmani,et al.  Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine , 2004, Urological Research.

[17]  K. Miyazawa,et al.  Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: evidence of activation peptide of human prothrombin , 2004, Urological research.

[18]  E. Neilson,et al.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R W Farndale,et al.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. , 1982, Connective tissue research.

[20]  L. Smith,et al.  Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. , 1975, Investigative urology.